Normal view MARC view ISBD view

Molecular detection of circulating tyrosinase mRNA: optimization in a preclinical xenograft mouse melanoma model and further evaluation in samples from advanced melanoma patients. [electronic resource]

By:

Gabri, Mariano R

Contributor(s):

Producer: 20080708Description: 555-9 p. digitalISSN:

1107-3756

Subject(s):

In: International journal of molecular medicine vol. 21

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

41 Evidence for the carriage of silver by sulphadimidine: inhibition of proteolytic enzymes.
by Ballinger, P M
42 Evidence for metal inhibition of tumour membrane-bound neutral protease and the control of tumour-induced target cell cytolysis.
by Steven, F S
43 Affinity preparation of a protein inhibitor recognising a cell surface protease.
by Steven, F S
44 The role of inhibitors in the fluorescent staining of benign naevus and malignant melanoma cells with 9-amino acridine and acridine orange.
by Steven, F S
45 Competitive inhibition of a tumour cell surface protease. A rapid technique for in vitro testing of selective targeting systems.
by Steven, F S
46 Inhibition properties of Sepharose-bound trypsin and a protease on the surface of Ehrlich ascites tumour cells.
by Steven, F S
47 Evidence for carriage of silver by sulphadimidine: haemolysis of human erythrocytes.
by Ballinger, P M
48 A simple fluorescent technique for the location of tumour cells in frozen sections of the head and neck region.
by Steven, F S
49 Effects of incarceration on HIV-infected individuals.
by Griffin, M M
50 Exchange of inhibitors and proteases at tumour cell surfaces.
by Steven, F S
51 Targeting adriamycin to tumour cells by means of an affinity ligand; a model system for drug delivery.
by Steven, F S
52 Fluorescent inhibitors of a cell surface protease used to locate leukaemia cells in kidney sections.
by Steven, F S
53 Inhibition of guanidinobenzoatase by a substrate for trypsin-like enzymes.
by Steven, F S
54 Studies on the interaction and exchange of inhibitors and proteases on the surface of tumour cells in frozen sections.
by Steven, F S
55 Labelling of tumour cells with a biotinylated inhibitor of a cell surface protease.
by Steven, F S
56 Further inhibition studies on guanidinobenzoatase, a trypsin-like enzyme associated with tumour cells.
by Steven, F S
57 Evidence for the functional similarity between tumour cell surface guanidinobenzoatase and tissue type plasminogen activator.
by Steven, F S
58 Studies on the activity of a protease associated with cells at the advancing edge of human tumour masses in frozen sections.
by Steven, F S
59 Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation.
by Raouf, A A
60 Inhibition of trypsin-like enzymes on cells with rhodamine-aprotinin.
by Steven, F S